Intestinal celiac disease - related autoantibodies
Authors:
Open Access
- 6 June 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1567416
Abstract
Celiac disease is a widespread autoimmune enteropathy with a genetic predisposition triggered by gluten intake. The only available treatment is a strict lifelong gluten-free diet. The diagnosis is based on the detection of serum celiac disease - related antibodies and histopathological analysis of duodenal biopsies. However, celiac disease has a wide spectrum of clinical, histological, and serological manifestations, and in some patients, the diagnosis can be challenging. Celiac disease - related antibodies antibodies are produced by intestinal B cells and can be detected in the small intestinal mucosa before their appearance in serum or before mucosal damage. In this paper, we reviewed the literature concerning the diagnostic value of intestinal celiac disease - related antibodies.Keywords
This publication has 121 references indexed in Scilit:
- Evaluating osteopontin levels in pediatric celiac disease: a potential indicator for mucosal atrophy and osteoporosisEuropean Journal of Pediatrics, 2024
- Diagnosis and Management of Celiac DiseaseJAMA, 2024
- Diagnosing and Monitoring Celiac Patients with Selective IgA Deficiency: Still an Open IssueDigestive Diseases and Sciences, 2021
- Substrates, inhibitors, and probes of mammalian transglutaminase 2Analytical Biochemistry, 2020
- Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac diseaseCellular and Molecular Life Sciences, 2018
- Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of miceAmino Acids, 2016
- Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a ReviewClinical Reviews in Allergy & Immunology, 2016
- Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoACellular and Molecular Life Sciences, 2009
- A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?Amino Acids, 2008
- Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitusDiabetologia, 2001